Baxter International Inc (BAX) shareholders
Close on Nov 17, 2026Market cap $13.33BP/E –Yield 2.02%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Pzena Investment Management LLC | 65,347,621 | 12.70% | 13G (passive) amendment | Mar 31, 2026 |
| Dodge & Cox | 57,396,370 | 11.20% | 13G (passive) amendment | Sep 30, 2025 |
| Abigail P. Johnson Joint filing with FMR LLC (10.30%) | 52,972,914 | 10.30% | 13G (passive) amendment | May 29, 2026 |
| Vanguard Capital Management | 38,033,907 | 7.36% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 33,109,852 | 6.40% | 13G (passive) amendment | Mar 31, 2026 |
| BlackRock Portfolio Management LLC | 30,382,653 | 5.90% | 13G (passive) amendment | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BAX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 81,842,105 | 15.82% | $1.74B | +2,441,441 | 0.03% |
| Pzena Investment Management LLC | 65,295,393 | 12.62% | $1.39B | +767,570 | 4.09% |
| Dodge & Cox | 58,386,345 | 11.29% | $1.24B | +1,131,775 | 0.65% |
| FMR LLC | 53,913,831 | 10.42% | $1.15B | +7,649,027 | 0.05% |
| Vanguard Capital Management LLC | 33,754,280 | 6.52% | $719.64M | +247,305 | 0.02% |
| Vanguard Portfolio Management LLC | 24,057,190 | 4.65% | $512.90M | +63,835 | 0.02% |
| State Street Corp | 20,600,468 | 3.98% | $439.40M | +620,511 | 0.01% |
| Greenhaven Associates Inc | 14,285,228 | 2.76% | $304.56M | −22,460 | 3.52% |
| Geode Capital Management, LLC | 14,123,689 | 2.73% | $300.59M | +360,724 | 0.02% |
| Invesco Ltd. | 12,361,881 | 2.39% | $263.56M | −759,290 | 0.02% |
| UBS Group AG | 9,529,309 | 1.84% | $203.16M | +5,209,812 | 0.03% |
| First Pacific Advisors, LP | 7,618,145 | 1.47% | $162.42M | +917,220 | 2.01% |
| Goldman Sachs Group Inc | 7,150,462 | 1.38% | $152.45M | +3,280,907 | 0.01% |
| Equity Investment Corp | 6,886,265 | 1.33% | $146.82M | +516,271 | 2.80% |
| Morgan Stanley | 6,359,790 | 1.23% | $135.59M | −988,182 | 0.01% |
| Bank Of America Corp /De/ | 6,237,950 | 1.21% | $132.99M | +71,817 | 0.01% |
| State Farm Mutual Automobile Insurance Co | 6,225,060 | 1.20% | $132.72M | – | 0.09% |
| Charles Schwab Investment Management Inc | 5,996,711 | 1.16% | $127.85M | +407,157 | 0.02% |
| Dimensional Fund Advisors LP | 5,612,144 | 1.08% | $119.68M | −319,647 | 0.02% |
| Northern Trust Corp | 4,864,004 | 0.94% | $103.70M | +516,686 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 685 | 557M | 100.0% | 106 / 250 | 194 / 74 | 48M | 21M |
| Q1 2026 | 662 | 529M | 100.0% | 82 / 190 | 261 / 120 | 114M | 74M |
| Q4 2025 | 710 | 552M | 100.0% | 112 / 240 | 237 / 120 | 91M | 48M |
| Q3 2025 | 732 | 510M | 98.5% | 87 / 252 | 269 / 116 | 81M | 69M |
| Q2 2025 | 774 | 500M | 96.7% | 71 / 266 | 298 / 127 | 31M | 22M |
| Q1 2025 | 841 | 491M | 95.0% | 124 / 277 | 305 / 96 | 36M | 26M |
| Q4 2024 | 824 | 483M | 93.3% | 114 / 250 | 333 / 170 | 46M | 36M |
| Q3 2024 | 899 | 475M | 91.7% | 121 / 305 | 320 / 93 | 109M | 33M |
| Q2 2024 | 879 | 462M | 89.2% | 98 / 278 | 324 / 140 | 45M | 61M |
| Q1 2024 | 935 | 479M | 92.5% | 115 / 313 | 322 / 79 | 29M | 25M |
| Q4 2023 | 913 | 475M | 91.9% | 127 / 262 | 376 / 111 | 75M | 48M |
| Q3 2023 | 909 | 448M | 86.7% | 77 / 285 | 378 / 133 | 61M | 53M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
476 funds held BAX in Q2 2026, 37% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BAX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 38,623,700 | 7.47% | $823.46M | 0.70% | Jun 30, 2026 |
| BlackRock Equity Dividend Fund | 18,965,221 | 3.67% | $496.13M | 2.43% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 16,397,162 | 3.17% | $349.59M | 0.02% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 13,382,913 | 2.59% | $285.32M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 11,833,128 | 2.29% | $252.28M | 0.13% | Jun 30, 2026 |
| Vanguard Windsor Fund | 10,439,598 | 2.02% | $273.10M | 1.08% | Jul 31, 2026 |
| Invesco S&P 500 Equal Weight ETF | 9,173,988 | 1.77% | $239.99M | 0.25% | Jul 31, 2026 |
| Fidelity Series Large Cap Stock Fund | 8,971,214 | 1.73% | $191.27M | 0.66% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 7,499,986 | 1.45% | $159.90M | 0.24% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 7,153,018 | 1.38% | $134.33M | 0.05% | May 31, 2026 |
| iShares Core S&P 500 ETF | 7,103,359 | 1.37% | $151.44M | 0.02% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 6,583,965 | 1.27% | $123.65M | 0.01% | May 31, 2026 |
| Fidelity Growth and Income Portfolio | 4,824,800 | 0.93% | $126.22M | 0.85% | Jul 31, 2026 |
| FPA Crescent Fund | 4,541,166 | 0.88% | $96.82M | 0.78% | Jun 30, 2026 |
| Vanguard Selected Value Fund | 3,672,438 | 0.71% | $96.07M | 1.38% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Andrew P. Hider | President and CEO, Director | 518,447 | 0.10% | Sep 3, 2026 |
| Terence John Rogers | EVP and CFO | 0 | – | Oct 2, 2026 |
| Bernard Heine | AVP, Finance InterimCAO&Cntrlr | 32,840 | 0.01% | Sep 18, 2026 |
| James Teaff | President, CCS | 30,370 | 0.01% | Sep 3, 2026 |
| Julie Foster | President, Front Line Care | 29,164 | 0.01% | Sep 3, 2026 |
| Steven P. Wallace | President, Adv. Surgery | 70,128 | 0.01% | Jun 3, 2026 |
| Anita A. Zielinski | SVP, Interim CFO, CAO & Cntrlr | 59,714 | 0.01% | Jun 3, 2026 |
| Maria Cecilia Soriano | Group Pres., ITT & Pharma. | 75,045 | 0.01% | Mar 10, 2026 |
| Joel T. Grade | EVP and CFO | 271,674 | 0.05% | Mar 10, 2026 |
| David S. Rosenbloom | EVP and General Counsel | 138,216 | 0.03% | Mar 10, 2026 |
| Reazur Rasul | EVP,Group Pres,Healthcare | 125,557 | 0.02% | Mar 10, 2026 |
| Cynthia Carlisle | Executive Vice President, CHRO | 0 | – | Mar 3, 2026 |
| Jeanne K. Mason | EVP, Chief HR Officer | 199,853 | 0.04% | Dec 16, 2025 |
| James W. Borzi | EVP,Chief Supply Chain Officer | 71,948 | 0.01% | Sep 4, 2025 |
| Alok Sonig | EVP,Group President,Pharma | 128,219 | 0.02% | Sep 4, 2025 |
| Heather Knight | EVP, Chief Operating Officer | 177,362 | 0.03% | Mar 10, 2025 |
| Christopher A. Toth | EVP, Group Pres, Kidney Care | 105,186 | 0.02% | Feb 4, 2025 |
| Jose E. Almeida | Chairman, CEO, President | 568,565 | 0.11% | Dec 17, 2024 |
| Michael R. McDonnell | Director | 14,647 | 0.00% | May 7, 2026 |
| Patricia Morrison | Director | 42,386 | 0.01% | May 7, 2026 |
| Nancy M. Schlichting | Director | 34,994 | 0.01% | May 7, 2026 |
| Jeffrey A. Craig | Director | 23,662 | 0.00% | May 7, 2026 |
| David S. Wilkes | Director | 37,076 | 0.01% | May 7, 2026 |
| David Brent Shafer | Director | 72,804 | 0.01% | May 7, 2026 |
| William A. Ampofo II | Director | 30,375 | 0.01% | May 7, 2026 |
| Amy McBride Wendell | Director | 44,235 | 0.01% | May 7, 2026 |
| Cathy R. Smith | Director | 30,345 | 0.01% | May 8, 2025 |
| Stephen H. Rusckowski | Director | 16,499 | 0.00% | May 8, 2025 |
| Stephen N. Oesterle | Director | 35,847 | 0.01% | May 8, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Julie Foster President, Front Line Care | Sep 2, 2026 | Tax withholding | −2,098 | $25.70 | $53.92K | 29,164 |
| Andrew P. Hider President and CEO, Director | Sep 2, 2026 | Tax withholding | −54,276 | $25.70 | $1.39M | 518,447 |
| James Teaff President, CCS | Sep 1, 2026 | Tax withholding | −750 | $25.48 | $19.11K | 30,370 |
| Steven P. Wallace President, Adv. Surgery | Jun 2, 2026 | Tax withholding | −153 | $18.68 | $2.86K | 70,128 |
| James Teaff President, CCS | Jun 2, 2026 | Tax withholding | −321 | $18.68 | $6.00K | 31,063 |
| Anita A. Zielinski SVP, Interim CFO, CAO & Cntrlr | Jun 1, 2026 | Award | +13,426 | – | – | 59,714 |
| Patricia Morrison Director | May 5, 2026 | Award | +12,836 | – | – | 42,386 |
| Nancy M. Schlichting Director | May 5, 2026 | Award | +12,836 | – | – | 34,994 |
| Jeffrey A. Craig Director | May 5, 2026 | Award | +12,836 | – | – | 23,662 |
| David S. Wilkes Director | May 5, 2026 | Award | +12,836 | – | – | 37,076 |
| David Brent Shafer Director | May 5, 2026 | Award | +12,836 | – | – | 72,804 |
| William A. Ampofo II Director | May 5, 2026 | Award | +12,836 | – | – | 30,375 |
| Amy McBride Wendell Director | May 5, 2026 | Award | +12,836 | – | – | 44,235 |
| Michael R. McDonnell Director | May 5, 2026 | Award | +12,836 | – | – | 14,647 |
| Joel T. Grade EVP and CFO | Mar 6, 2026 | Tax withholding | −8,153 | $17.69 | $144.23K | 271,674 |
| Reazur Rasul EVP,Group Pres,Healthcare | Mar 6, 2026 | Tax withholding | −12,674 | $17.69 | $224.20K | 125,557 |
| Anita A. Zielinski SVP, CAO and Controller | Mar 6, 2026 | Tax withholding | −1,932 | $17.69 | $34.18K | 46,281 |
| Maria Cecilia Soriano Group Pres., ITT & Pharma. | Mar 6, 2026 | Tax withholding | −2,848 | $17.69 | $50.38K | 75,045 |
| David S. Rosenbloom EVP and General Counsel | Mar 6, 2026 | Tax withholding | −6,620 | $17.69 | $117.11K | 138,216 |
| David S. Rosenbloom EVP and General Counsel | Mar 2, 2026 | Tax withholding | −1,336 | $19.69 | $26.31K | 144,837 |
| Maria Cecilia Soriano Group Pres., ITT & Pharma. | Mar 2, 2026 | Tax withholding | −1,852 | $19.69 | $36.47K | 77,894 |
| Reazur Rasul EVP,Group Pres,Healthcare | Mar 2, 2026 | Tax withholding | −1,614 | $19.69 | $31.78K | 138,231 |
| Andrew P. Hider President and CEO, Director | Feb 27, 2026 | Award | +201,804 | – | – | 572,239 |
| Anita A. Zielinski SVP, CAO and Controller | Feb 27, 2026 | Award | +30,864 | – | – | 48,214 |
| David S. Rosenbloom EVP and General Counsel | Feb 27, 2026 | Award | +26,709 | – | – | 146,173 |
| Joel T. Grade EVP and CFO | Feb 27, 2026 | Award | +42,735 | – | – | 279,828 |
| Maria Cecilia Soriano Group Pres., ITT & Pharma. | Feb 27, 2026 | Award | +23,742 | – | – | 79,748 |
| Cynthia Carlisle Executive Vice President, CHRO | Feb 27, 2026 | Award | +11,871 | – | – | 29,677 |
| Cynthia Carlisle Executive Vice President, CHRO | Feb 27, 2026 | Award | +17,806 | – | – | 17,806 |
| Michael R. McDonnell Director | Feb 13, 2026 | Award | +1,811 | – | – | 1,811 |
| Joel T. Grade EVP and CFO | Feb 9, 2026 | Award | +30,504 | – | – | 246,048 |
| Joel T. Grade EVP and CFO | Feb 9, 2026 | Tax withholding | −9,144 | $21.73 | $198.70K | 236,904 |
| Maria Cecilia Soriano Group Pres., ITT & Pharma. | Feb 9, 2026 | Tax withholding | −918 | $21.73 | $19.95K | 56,006 |
| Maria Cecilia Soriano Group Pres., ITT & Pharma. | Feb 9, 2026 | Award | +2,273 | – | – | 56,924 |
| David S. Rosenbloom EVP and General Counsel | Feb 9, 2026 | Award | +17,055 | – | – | 124,689 |
| David S. Rosenbloom EVP and General Counsel | Feb 9, 2026 | Tax withholding | −5,225 | $21.73 | $113.54K | 119,464 |
| Reazur Rasul EVP,Group Pres,Healthcare | Feb 9, 2026 | Tax withholding | −5,770 | $21.73 | $125.38K | 139,846 |
| Reazur Rasul EVP,Group Pres,Healthcare | Feb 9, 2026 | Award | +18,951 | – | – | 145,616 |
| Jeanne K. Mason EVP, Chief HR Officer | Dec 12, 2025 | Tax withholding | −650 | $19.15 | $12.45K | 199,853 |
| Joel T. Grade EVP and CFO | Dec 1, 2025 | Tax withholding | −8,288 | $19.08 | $158.14K | 215,151 |
| Alok Sonig EVP,Group President,Pharma | Sep 2, 2025 | Tax withholding | −3,191 | $24.17 | $77.13K | 128,219 |
| James W. Borzi EVP,Chief Supply Chain Officer | Sep 2, 2025 | Tax withholding | −1,848 | $24.17 | $44.67K | 71,948 |
| Joel T. Grade EVP and CFO | Sep 2, 2025 | Award | +102,712 | – | – | 222,560 |
| Andrew P. Hider President and CEO, Director | Sep 2, 2025 | Award | +131,813 | – | – | 368,050 |
| Andrew P. Hider President and CEO, Director | Sep 2, 2025 | Award | +236,237 | – | – | 236,237 |
| David Brent Shafer Director | Aug 19, 2025 | Tax withholding | −31,337 | $24.33 | $762.43K | 59,446 |
| David S. Rosenbloom EVP and General Counsel | Jun 2, 2025 | Tax withholding | −16,548 | $29.55 | $488.99K | 106,327 |
| William A. Ampofo II Director | May 6, 2025 | Award | +7,183 | – | – | 17,299 |
| Cathy R. Smith Director | May 6, 2025 | Award | +7,183 | – | – | 30,345 |
| Amy McBride Wendell Director | May 6, 2025 | Award | +7,183 | – | – | 31,222 |
| David S. Wilkes Director | May 6, 2025 | Award | +7,183 | – | – | 23,906 |
| Stephen N. Oesterle Director | May 6, 2025 | Award | +7,183 | – | – | 35,847 |
| Stephen H. Rusckowski Director | May 6, 2025 | Award | +7,183 | – | – | 16,499 |
| Patricia Morrison Director | May 6, 2025 | Award | +7,183 | – | – | 29,137 |
| Nancy M. Schlichting Director | May 6, 2025 | Award | +7,183 | – | – | 21,850 |
| Jeffrey A. Craig Director | May 6, 2025 | Award | +7,183 | – | – | 10,672 |
| David S. Rosenbloom EVP and General Counsel | Mar 6, 2025 | Tax withholding | −4,922 | $35.44 | $174.44K | 104,780 |
| David S. Rosenbloom EVP and General Counsel | Mar 6, 2025 | Award | +17,658 | – | – | 122,438 |
| Alok Sonig EVP,Group President,Pharma | Mar 6, 2025 | Award | +29,966 | – | – | 130,298 |
| Alok Sonig EVP,Group President,Pharma | Mar 6, 2025 | Tax withholding | −10,839 | $35.44 | $384.13K | 100,332 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Baxter International's stock actually held short. Settlement fails (shares not delivered on time) peaked at 113,283 shares on Oct 2, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Stephen N. Oesterle Rev Trust Former Affiliate | May 18, 2026 | 36,347 | $645.24K | May 18, 2026 | Open Market Purchase |
| Brian Stevens Officer | Sep 16, 2024 | 976 | $39.05K | Sep 16, 2024 | OTHER SP SHARES |
| Brian Stevens Officer | Sep 13, 2024 | 16,063 | $639.46K | Sep 13, 2024 | PERFORMANCE SHARES |
| Jeanne K. Mason Officer | Mar 1, 2024 | 64,488 | $2.62M | Mar 1, 2024 | Stock Option Exercise |
Congress trades
40 trades in Baxter International reported by 17 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Michael T. McCaul TX10 · spouse | Bought | Jan 13, 2026 | $50K–100K | Feb 11, 2026 |
| Lisa McClain MI09 · spouse | Sold | Oct 31, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Sep 25, 2025 | $1K–15K | Oct 22, 2025 |
| Lisa McClain MI09 · spouse | Sold | Aug 4, 2025 | $1K–15K | Sep 12, 2025 |
| Lisa McClain MI09 · spouse | Bought | Jul 22, 2025 | $1K–15K | Aug 13, 2025 |
| Rob Bresnahan PA08 | Bought | May 15, 2025 | $1K–15K | Jun 9, 2025 |
| Debbie Wasserman Schultz FL25 · child | Bought | Nov 18, 2024 | $1K–15K | Nov 20, 2024 |
| Earl Blumenauer OR03 · spouse | Bought | Jul 9, 2024 | $15K–50K | Aug 6, 2024 |
| Robert J. Wittman VA01 | Sold | Jan 20, 2023 | $1K–15K | Feb 15, 2023 |
| William R. Keating MA09 | Sold | Dec 5, 2022 | $1K–15K | Dec 21, 2022 |
| Robert J. Wittman VA01 | Bought | Jul 15, 2022 | $1K–15K | Aug 10, 2022 |
| Robert J. Wittman VA01 | Sold (part) | Jun 16, 2022 | $1K–15K | Jul 8, 2022 |
| William R. Keating MA09 | Bought | Apr 14, 2021 | $1K–15K | Apr 27, 2021 |
| William R. Keating MA09 | Bought | Mar 17, 2021 | $1K–15K | Apr 27, 2021 |
| Peter Meijer MI03 | Sold | Feb 16, 2021 | $1K–15K | Mar 16, 2021 |
| Dean Phillips MN03 | Sold (part) | Dec 18, 2020 | $1K–15K | Jan 9, 2021 |
| Dean Phillips MN03 | Bought | Sep 23, 2020 | $1K–15K | Oct 9, 2020 |
| Lois Frankel FL22 | Sold | May 27, 2020 | $1K–15K | Jun 28, 2020 |
| Dean Phillips MN03 | Bought | Apr 2, 2020 | $1K–15K | May 7, 2020 |
| Dean Phillips MN03 | Bought | Feb 28, 2020 | $1K–15K | Mar 12, 2020 |
| Lois Frankel FL22 | Sold (part) | Jan 29, 2020 | $1K–15K | Feb 24, 2020 |
| Dean Phillips MN03 | Sold | Nov 22, 2019 | $1K–15K | Dec 11, 2019 |
| Dean Phillips MN03 | Sold (part) | Sep 11, 2019 | $1K–15K | Oct 11, 2019 |
| Dean Phillips MN03 | Bought | Aug 13, 2019 | $1K–15K | Sep 16, 2019 |
| Lois Frankel FL22 | Sold (part) | Feb 28, 2019 | $1K–15K | Mar 27, 2019 |
| Susie Lee NV03 · joint account | Sold | Feb 27, 2019 | $1K–15K | Mar 12, 2019 |
| Lois Frankel FL22 | Sold (part) | Jul 18, 2018 | $1K–15K | Aug 24, 2018 |
| Gary Palmer AL06 · spouse | Sold | Nov 27, 2017 | $1K–15K | Sep 29, 2018 306 days late |
| Richard L. Hanna NY22 | Sold | Dec 28, 2016 | $15K–50K | Jan 18, 2017 |
| Mo Brooks AL05 · joint account | Sold | Aug 31, 2016 | $1K–15K | Oct 10, 2016 |
| Lois Frankel FL22 | Bought | Jan 15, 2016 | $1K–15K | Feb 29, 2016 |
| Lois Frankel FL22 | Bought | Jan 15, 2016 | $1K–15K | Jan 28, 2016 |
| Lois Frankel FL22 | Bought | Nov 23, 2015 | $1K–15K | Jan 8, 2016 46 days late |
| Raúl M. Grijalva AZ03 | Sold | Oct 15, 2015 | $1K–15K | Nov 2, 2015 |
| K. Michael Conaway TX11 · joint account | Sold | Jul 31, 2015 | $1K–15K | Aug 3, 2015 |
| K. Michael Conaway TX11 | Sold | Jul 31, 2015 | $1K–15K | Aug 3, 2015 |
| Frank A. LoBiondo NJ02 | Sold | Jul 30, 2015 | $1K–15K | Jul 20, 2016 356 days late |
| Raúl M. Grijalva AZ03 | Bought | Jul 29, 2015 | $1K–15K | Aug 13, 2015 |
See a number that looks wrong?